Breast Cancer Res 2006, 8:
R36.CrossRefPubMed 4. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis C, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D, www.selleckchem.com/products/lazertinib-yh25448-gns-1480.html Georgoulias V: Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 2002, 20: 3404–3412.CrossRefPubMed 5. Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M: Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol 2005, 26: 721–730.PubMed 6. Kwon S, Kang SH, Ro J, Jeon CH, Park JW, Lee ES: The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma. Cancer 2005, 104: 251–256.CrossRefPubMed 7. Benoy IH, Elst H, Auwera I, Van Laere S, van Dam P, Van Marck E, Scharpe S, Vermeulen PB, Dirix LY: PKC412 in vitro Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial
cells in bone marrow aspirates of patients with breast https://www.selleckchem.com/products/AZD8931.html cancer. Br J Cancer 2004, 91: 1813–1820.CrossRefPubMed 8. Hayes DF, Walker TM, Singh B, Vitetta ES, Uhr JW, Gross S, Rao C, Doyle GV, Terstappen Bay 11-7085 LW: Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol 2002, 21: 1111–1117.PubMed 9. Hauch S, Zimmermann S, Lankiewicz S, Zieglschmid
V, Bocher O, Albert WH: The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. Anticancer Res 2007, 27: 1337–1341.PubMed 10. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23: 1420–1430.CrossRefPubMed 11. Ge M, Shi D, Wu Q, Wang M, Li L: Fluctuation of circulating tumor cells in patients with lung cancer by real-time fluorescent quantitative-PCR approach before and after radiotherapy. J Cancer Res Ther 2005, 1: 221–226.CrossRefPubMed 12. Zhong LP, Zhao SF, Chen GF, Ping FY, Xu ZF, Hu JA: Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. Arch Oral Biol 2006, 51: 1112–1119.CrossRefPubMed 13.